Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Policy
Novartis will set up a new drug discovery research facility at the Zhangjiang Hi-Tech Park in Shanghai. Employing as many as 400 scientists, it will be among the largest foreign-owned drug discovery centers in China. The company plans to spend $100 million to establish the facility. This money will cover the cost of setting up a temporary R&D center that will begin operating in May 2007 as well as the construction of a more permanent facility with 38,000 m2 of floor space. The firm expects to find most of its scientific staff in the Shanghai area.
This article has been sent to the following recipient: